McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD 880.11
-4.78 (-0.54%)
At close: Nov 28, 2025
McKesson Market Cap
McKesson has a market cap or net worth of 82.16 billion as of November 28, 2025. Its market cap has increased by 33.58% in one year.
Market Cap
82.16B
Enterprise Value
87.53B
Revenue
287.97B
Ranking
n/a
PE Ratio
27.38
Stock Price
880.11
Market Cap Chart
Since November 10, 1994, McKesson's market cap has increased from 904.45M to 82.16B, an increase of 8,983.67%. That is a compound annual growth rate of 15.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 82.16B | 42.17% |
| Dec 31, 2024 | 57.79B | 19.48% |
| Dec 29, 2023 | 48.37B | 9.56% |
| Dec 30, 2022 | 44.14B | 57.50% |
| Dec 31, 2021 | 28.03B | 37.03% |
| Dec 31, 2020 | 20.45B | 8.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.39B |
| GSK plc | 72.40B |
| Haleon | 33.03B |
| Smith & Nephew | 10.71B |
| ConvaTec Group | 4.60B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.68B |